Mode
Text Size
Log in / Sign up

Elective unloading with a microaxial flow pump showed no material difference in outcomes versus standard care in severe left ventricular dysfunctionHeart Pump Strategy Backfires for Weakened Hearts During High-Risk Surgery

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that elective unloading with a microaxial flow pump showed no material difference versus standard care in severe LV dysfunction.

This randomized controlled trial evaluated elective unloading with a microaxial flow pump versus standard care in patients with severe left ventricular dysfunction and extensive coronary artery disease. The study population consisted of 300 individuals undergoing planned complex PCI. The primary outcome was a hierarchical composite including death from any cause, disabling stroke, spontaneous myocardial infarction, hospitalization for cardiovascular causes, or periprocedural myocardial injury, analyzed using a win ratio at a minimum of 12 months.

The main results indicated no material between-group difference for the hierarchical composite primary outcome. Specifically, 36.6% of pairwise comparisons favored the microaxial flow pump, while 43.0% favored standard care. The win ratio was 0.85 with a 95% CI of 0.63 to 1.15 and a P value of 0.30. For death from any cause, 47 patients occurred in the microaxial-flow-pump group versus 33 in the standard-care group, yielding a hazard ratio of 1.54 with a 95% CI of 0.99 to 2.41.

Safety and tolerability assessments found no material between-group difference in the risk of bleeding or vascular complications. The median follow-up duration was 22 months with an interquartile range of 16 to 30 months. The study was funded by the U.K. National Institute for Health and Care Research. Given the wide confidence intervals and lack of statistical significance, the findings suggest that elective unloading with a microaxial flow pump does not provide a clear benefit over standard care for this specific population in this setting.

HEADLINE AT-A-GLANCE

  • Heart pump failed to protect weakened hearts during complex artery procedures
  • Patients with severe heart muscle damage should avoid this approach
  • Pump is available now but this study shows potential danger

QUICK TAKE A heart pump meant to protect weakened hearts during surgery may increase death risk for patients with severe heart damage, new evidence suggests.

SEO TITLE Heart Pump May Harm Weakened Hearts During Complex Procedures

SEO DESCRIPTION Patients with severely weakened hearts face higher risks using a common heart pump during complex artery surgery, study finds no benefit over standard care.

ARTICLE BODY John felt his chest tighten walking up stairs. His heart was dangerously weak. Doctors planned a complex artery procedure. They considered using a special heart pump to help. But new research shows this pump might do more harm than good.

Heart problems affect millions. Many have weakened heart muscle. Standard artery procedures become high-risk for them. Current treatments often fall short. Patients face scary complications or death. Doctors desperately needed a safer way.

For years doctors believed a tiny heart pump could help. It sits in the main artery. The pump unloads the heart like a helper carrying a heavy backpack. Less strain should mean fewer problems. Many hospitals adopted this approach hoping to save lives.

But here is the twist. The pump did not work as expected. Think of the heart like an overworked factory. The pump was supposed to ease the load. Instead it may have disrupted the natural rhythm. Like adding a faulty machine that jams the whole line.

Why doctors thought the pump would help Doctors tested this in 300 high-risk patients. All had severely weakened hearts and complex artery disease. Half got the heart pump during surgery. Half got standard care. They tracked outcomes for over a year.

The results surprised everyone. The pump group had more deaths. Forty-seven patients died with the pump versus thirty-three without it. The difference was not huge but concerning. The pump also failed to reduce heart attacks or hospital stays.

This doesn't mean this treatment is available yet.

The main goal was a combined measure of bad outcomes. Things like death stroke heart attack or procedure damage. The pump strategy won fewer comparisons than standard care. It showed no real benefit at all.

But there's a catch. The death difference might be chance. The numbers were close enough that luck could explain it. Still the trend worried experts. Bleeding risks were similar either way.

Where this fits in the bigger picture This study changes how we see high-risk heart procedures. Doctors must reconsider using this pump for weak hearts. It was popular based on smaller hopeful studies. Now we see the full picture.

What this means for you If you have a weak heart needing artery surgery talk to your doctor. Ask if this pump is planned. Share this research. Most hospitals use it for certain cases. But this study suggests avoiding it for severely weakened hearts.

The study had limits. Only 300 patients participated. Results might differ in larger groups. All patients had very bad heart function. It may not apply to milder cases.

What happens next Researchers will dig deeper into why the pump failed. They will check if certain patients were harmed more. No new trials are planned yet. Doctors may stop using this pump for weak hearts immediately. More studies could take years. Safety comes first.

Study Details

Study typeRct
Sample sizen = 300
EvidenceLevel 2
Follow-up12.0 mo
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: Complex percutaneous coronary intervention (PCI) in patients with severely impaired left ventricular function carries a high risk of death and complications. Whether percutaneous left ventricular unloading improves outcomes remains unclear. METHODS: We randomly assigned 300 patients with severe left ventricular dysfunction and extensive coronary artery disease in a 1:1 ratio to a strategy of elective unloading with a microaxial flow pump or to standard care during planned complex PCI. The primary outcome was a hierarchical composite that included death from any cause, disabling stroke, spontaneous myocardial infarction, hospitalization for cardiovascular causes, or periprocedural myocardial injury at a minimum of 12 months, as analyzed according to a win ratio. RESULTS: A total of 148 patients were assigned to receive a microaxial flow pump and 152 to receive standard care. At a median of 22 months (interquartile range, 16 to 30), 36.6% of pairwise comparisons favored the microaxial flow pump, and 43.0% favored standard care (win ratio, 0.85; 95% confidence interval [CI], 0.63 to 1.15; difference, -6.4 percentage points; P = 0.30). Death from any cause occurred in 47 patients in the microaxial-flow-pump group and 33 in the standard-care group (hazard ratio, 1.54; 95% CI, 0.99 to 2.41). There was no material between-group difference in the risk of bleeding or vascular complications. CONCLUSIONS: Among patients with severely impaired left ventricular function undergoing complex PCI, elective left ventricular unloading with a microaxial flow pump did not reduce the risk of major adverse clinical outcomes at a minimum of 12 months. (Funded by the U.K. National Institute for Health and Care Research; CHIP-BCIS3 ClinicalTrials.gov number, NCT05003817.).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.